NT-CLP-03

• Research type

  Research Study

• Full title

  A Prospective, Multi-Center, Non-randomized, Single arm, Open label, Supplemental Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter in Facilitating Crossing Chronic Total Occlusion (CTO) Coronary Lesions.

• IRAS ID

  249017

• Contact name

  Wojciech Zasada

• Contact email

  wojciech.zasada@kcri.org

• Sponsor organisation

  Nitiloop Ltd.

• Duration of Study in the UK

  0 years, 6 months, 31 days

• Research summary

  The purpose of this trial is to evaluate the safety and effectiveness of the NovaCross™ micro-catheter when used to facilitate crossing of Chronic Total Occlusion (CTO) lesions in coronary arteries. The procedure will be conducted on consenting patients diagnosed with a CTO in a coronary vessel that requires revascularization after a previously failed attempt to cross or that is refractory to 10 minutes of conventional 'workhorse' guidewire crossing.

• REC name

  London - Chelsea Research Ethics Committee

• REC reference

  18/LO/1723

• Date of REC Opinion

  15 Oct 2018

• REC opinion

  Further Information Favourable Opinion